Press Release

COVID-19 Diagnostics Market 2021 Size & Share | Market worth USD 11.40 billion with 7.9% CAGR by 2027

The global “COVID-19 Diagnostics Market” is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027”. According to Johns Hopkins University, global COVID-19 infections reached 100,000 in just 60 days, growing to 200,000 in the next 12-14 days, and the recent addition of 100,000 cases has taken only 3 days.

The calculation of the spread of this disease is based on the estimation of the “reproduction number” or R Naught (Ro). The UK Research and Innovation organization states that if the Ro goes above 1, exponential growth will be witnessed. As per a study published in the Journal of Clinical Medicine based on the virus transmission rate in Wuhan, the Ro was computed to be between 2.49 and 2.63. Such rapid transmission of the virus has surged the demand for coronavirus diagnostics tools and kits, which is boosting the growth of this market.

Major COVID-19 Diagnostics Market Key players covered in the report include:

  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Abbott
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Hoffmann-La Roche Ltd
  • Danaher Corporation

Get Request a Sample Copy of the COVID-19 Diagnostics Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/covid-19-diagnostics-market-103291

COVID-19 Diagnostics Market Analysis 2021:

Concerted Efforts towards Developing COVID Detection Tests to Accelerate Growth

With the COVID-19 pandemic showing no signs of abatement, medical and regulatory bodies are collaborating to encourage innovation and speed up research in developing coronavirus detection tools. For instance, in April 2020, the National Institutes of Health in the US announced the launch of Rapid Acceleration of Diagnostics (RADx) initiative with a funding of USD 1.5 billion to commercialize and widen the accessibility of COVID-19 testing. Similarly, in June 2020, the US Food and Drug Administration (FDA) joined the COVID-19 Diagnostics Evidence Accelerator created by the Friends of Cancer Research and Reagan-Udall Foundation with the aim to evaluate the performance of PCR and antibody tests for COVID. Together, these and similar initiatives are expected to augment the COVID-19 diagnostics market growth throughout 2020.

High Number of COVID-19 Cases to Give North America Leading Market Position

The United States is one of the worst-hit countries in the world by the coronavirus pandemic, with the number of cases as of June 2020 standing at 2.68 million and 129,000 deaths. In response, the US government is injecting more funds into medical research facilities to accelerate development of COVID-19 diagnostics and widen the testing net in the country. The region’s market size in 2019 stood at USD 2.17 billion.

In Europe, the virus is spreading at a furious pace, with the UK, Italy, Spain, France, and Germany having the highest number of cases. Quick adoption of advanced detection tools in the region will enable it to expand its footprint in the COVID-19 diagnostics market share in the immediate future. Heavy investments by governments in Asia Pacific in the healthcare sector are expected to favor market growth in the region.

Regulatory Support to Novel Diagnostic Solutions to Encourage Innovation

The coronavirus is tightening its hold on the world and COVID-19 Diagnostics and governments are in a race against time to develop and launch quick and accurate diagnostic tests for this deadly virus. As a result, bodies such as the FDA are providing the necessary support to companies by removing unnecessary regulatory barriers, which is encouraging other players to innovate.

Industry Developments:

May 2020: Sofia 2 SARS Antigen FIA test developed by Quidel was green lit by the FDA, making it the first antigen test approved in the US for the detection of COVID-19. These tests identify unique protein fragments found on the outer walls of the coronavirus and deliver quick results.

March 2020: The US FDA cleared Abbott’s molecular point-of-care test for detection of COVID in patients through its Emergency Use Authorization (EUA). The test promises to deliver positive results in 5 minutes and negative results in 13 minutes.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/covid-19-diagnostics-market-103291

Table of Content:

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Overview: Guidelines for COVID-19 Diagnosis
    • New Product Launch
    • Prevalence of COVID-19 Disease
    • Impact of COVID-19 on Diagnostics Market
    • Overview of Regulatory Scenario
    • Impact on Supply Chain of Diagnostics Amid the Pandemic
    • Key Industry Developments – Mergers, Acquisitions, and Partnerships
  • Global COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Product
      • Instruments
      • Reagents & Kits
    • Market Analysis, Insights and Forecast By Technology
      • Polymerase Chain Reaction (PCR)
      • Enzyme-linked Immunosorbent Assay (ELISA)
      • Point-of-care (POC)
      • Others
    • Market Analysis, Insights and Forecast By Sample Type
      • Oropharyngeal & Nasopharyngeal Swabs
      • Blood
      • Urine
      • Others
    • Market Analysis, Insights and Forecast By End User
      • Hospitals & Clinics
      • Laboratories & Diagnostic Centers
      • Research Institute
      • Others
    • Market Analysis, Insights and Forecast By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • North America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2027
      • Key Findings / Summary
      • Market Analysis, Insights and Forecast By Product
        • Instruments
        • Reagents & Kits
      • Market Analysis, Insights and Forecast By Technology
        • Polymerase Chain Reaction (PCR)
        • Enzyme-linked Immunosorbent Assay (ELISA)
        • Point-of-care (POC)
        • Others
      • Market Analysis, Insights and Forecast By Sample Type
        • Oropharyngeal & Nasopharyngeal Swabs
        • Blood
        • Urine
        • Others
      • Market Analysis, Insights and Forecast By End User
        • Hospitals & Clinics
        • Laboratories & Diagnostic Centers
        • Research Institute
        • Others
      • Market Analysis, Insights and Forecast By Country
        • S.
        • Canada
      • Europe COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2027
        • Key Findings / Summary
        • Market Analysis, Insights and Forecast By Product
          • Instruments
          • Reagents & Kits
        • Market Analysis, Insights and Forecast By Technology
          • Polymerase Chain Reaction (PCR)
          • Enzyme-linked Immunosorbent Assay (ELISA)
          • Point-of-care (POC)
          • Others
        • Market Analysis, Insights and Forecast By Sample Type
          • Oropharyngeal & Nasopharyngeal Swabs
          • Blood
          • Urine
          • Others
        • Market Analysis, Insights and Forecast By End User
          • Hospitals & Clinics
          • Laboratories & Diagnostic Centers
          • Research Institute
          • Others
        • Market Analysis, Insights and Forecast By Country/Sub-region
          • K.
          • Germany
          • France
          • Spain
          • Italy
          • Scandinavia
          • Rest of Europe
        • Asia Pacific COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2027
          • Key Findings / Summary
          • Market Analysis, Insights and Forecast By Product
            • Instruments
            • Reagents & Kits
          • Market Analysis, Insights and Forecast By Technology
            • Polymerase Chain Reaction (PCR)
            • Enzyme-linked Immunosorbent Assay (ELISA)
            • Point-of-care (POC)
            • Others
          • Market Analysis, Insights and Forecast By Sample Type
            • Oropharyngeal & Nasopharyngeal Swabs
            • Blood
            • Urine
            • Others
          • Market Analysis, Insights and Forecast By End User
            • Hospitals & Clinics
            • Laboratories & Diagnostic Centers
            • Research Institute
            • Others
          • Market Analysis, Insights and Forecast By Country/Sub-region
            • Japan
            • China
            • India
            • Australia
            • Southeast Asia
            • Rest of Asia Pacific

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Portable Ultrasound Market: Royal Philips Introduces Lumify to Adapt to Major Demographic Changes in Japan, reports Fortune Business Insights™

Vision Care Market to Exhibit a CAGR of 5.6%; Increasing Cases of Cataract will Augur Healthy for the Market, says Fortune Business Insights

Global COVID-19 Diagnostics Market | Expected to Reach USD 11.40 billion (at CAGR of 7.9%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Medical Electrodes Market | Expected to Reach USD 822.13 million (at CAGR of 3.9%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Spirometer Market | Expected to Reach USD 716.8 million (at CAGR of 4.7%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Ventilator Market | Expected to Reach USD 9.13 billion (at CAGR of 5.0%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Clear Aligners Market | Expected to Reach USD 10.04 billion (at CAGR of 19.7%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Hearing Aids Market | Expected to Reach USD 13.38 billion (at CAGR of 8.2%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Global Teledermatology Market | Expected to Reach USD 44.86 billion (at CAGR of 24.3%) | COVID-19 Impact Covered | Forecast Period 2021-2027

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close